188 related articles for article (PubMed ID: 15202000)
41. Oncogenic potential of EAG K(+) channels.
Pardo LA; del Camino D; Sánchez A; Alves F; Brüggemann A; Beckh S; Stühmer W
EMBO J; 1999 Oct; 18(20):5540-7. PubMed ID: 10523298
[TBL] [Abstract][Full Text] [Related]
42. Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma.
Cui Z; Zhang L; Hua Z; Cao W; Feng W; Liu Z
Oncol Rep; 2007 Apr; 17(4):829-33. PubMed ID: 17342323
[TBL] [Abstract][Full Text] [Related]
43. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
44. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
Ueda M; Misaki O; Yamada T; Okamoto Y; Goto M; Maeda T; Okamura S; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
[TBL] [Abstract][Full Text] [Related]
45. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
[TBL] [Abstract][Full Text] [Related]
46. [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Yoshinouchi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2513-21. PubMed ID: 2614188
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of tau downregulated the mRNA levels of Kv channels and improved proliferation in N2A cells.
Li X; Hu X; Li X; Hao X
PLoS One; 2015; 10(1):e0116628. PubMed ID: 25590133
[TBL] [Abstract][Full Text] [Related]
48. [Morphological studies on human uterine cancer cells in vitro (author's transl)].
Matsuura M; Kusanagi T; Kudo R
Acta Obstet Gynaecol Jpn; 1981 May; 33(5):690-8. PubMed ID: 7234356
[TBL] [Abstract][Full Text] [Related]
49. [Cytogenetic aspects of uterine carcinomas].
De Cecco L; Rugiati S; Sbernini R
Quad Clin Ostet Ginecol; 1966 Sep; 21(9):562-73. PubMed ID: 5993024
[No Abstract] [Full Text] [Related]
50. Auxiliary KCNE subunits modulate both homotetrameric Kv2.1 and heterotetrameric Kv2.1/Kv6.4 channels.
David JP; Stas JI; Schmitt N; Bocksteins E
Sci Rep; 2015 Aug; 5():12813. PubMed ID: 26242757
[TBL] [Abstract][Full Text] [Related]
51. [Endometrial adenocarcinoma with epidermoid carcinoma of the uterine cervix].
Bellorini R; Zanetta G; Cervini D
Chir Ital; 1981 Jun; 33(3):746-51. PubMed ID: 7307213
[No Abstract] [Full Text] [Related]
52. Involvement of CD147 isoform‑4 in the proliferation of SiHa cells: a possible molecular mechanism of cervical cancer.
Wu Y; Zhou X; Zheng PS
Oncol Rep; 2011 Sep; 26(3):717-24. PubMed ID: 21687950
[TBL] [Abstract][Full Text] [Related]
53. Shadow cell differentiation in tumours of the colon and uterus.
Zámecník M; Michal M
Zentralbl Pathol; 1995 Apr; 140(6):421-6. PubMed ID: 7538784
[TBL] [Abstract][Full Text] [Related]
54. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Chen SZ; Jiang M; Zhen YS
Cancer Chemother Pharmacol; 2005 Aug; 56(2):212-20. PubMed ID: 15812674
[TBL] [Abstract][Full Text] [Related]
55. Determining the correct stoichiometry of Kv2.1/Kv6.4 heterotetramers, functional in multiple stoichiometrical configurations.
Möller L; Regnier G; Labro AJ; Blunck R; Snyders DJ
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9365-9376. PubMed ID: 32284408
[TBL] [Abstract][Full Text] [Related]
56. Voltage-gated potassium ion channels in colon cancer.
Abdul M; Hoosein N
Oncol Rep; 2002; 9(5):961-4. PubMed ID: 12168055
[TBL] [Abstract][Full Text] [Related]
57. [Estramustine phosphate, estrogen conjugated with nitrogen mustard inhibits the growth of endometrial cancer cells in vitro].
Hasegawa M; Sakamoto H; Deng X; Ige Y; Shirakawa T; Ohtani K; Takami M; Takami T; Ishii Y; Satoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 May; 47(5):479-85. PubMed ID: 7775815
[TBL] [Abstract][Full Text] [Related]
58. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.
Fujimoto T; Nishikawa A; Iwasaki M; Akutagawa N; Teramoto M; Kudo R
Gynecol Oncol; 2004 May; 93(2):446-53. PubMed ID: 15099960
[TBL] [Abstract][Full Text] [Related]
59. [Effect of anticancer drugs on in vitro survival of cell lines derived from various gynecologic tumors (author's transl)].
Sekiya S; Takamizawa H
Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):373-6. PubMed ID: 6163305
[TBL] [Abstract][Full Text] [Related]
60. Differences between cell lines of uterine cervical glassy cell carcinoma and large cell nonkeratinizing squamous cell carcinoma.
Ishiwata I; Ishiwata C; Soma M; Ono I; Nakaguchi T; Nozawa S; Ishikawa H
Anal Quant Cytol Histol; 1990 Aug; 12(4):290-8. PubMed ID: 1698374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
